The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

The MarketWatch News Department was not involved in the creation of this content. PHILADELPHIA and LONDON, Dec. 18, 2025 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) contract ...

Impella, which J&J touts as the world’s smallest heart pump, has a range of devices used for various heart conditions. Lexeo ...

Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...

Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

The new method is designed to focus specifically on pain-related signals, without interfering with normal activity in other parts of the brain. A new preclinical study has identified a gene therapy ap ...

Medscape Medical News talked with researcher Stacie Dusetzina about the prospects for a single-payer program to help with the very high upfront costs of cell and gene therapies, many of which are in ...

Over the last four years, Shriners Children’s St. Louis researchers have been working to develop a new way to prevent the effects of childhood obesity. Now, using gene therapy, Shriners Children’s St.

A Yale research team has created a new computer tool that can pinpoint when exactly genes turn on and off over time during brain development - a finding that may one day help doctors identify the ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or inactivating genes. Precisely fixing disease-causing mutations is far more ...